Skip to main content

Table 3 Major compounds in CKI identified by HPLC–MS

From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

No. Theoretical value PPM Time (min) MS/MS ions Structure Rresumption
1 218.10577 − 4.06 6.007 152.01067, 123.00785, 108.02056, 85.02821, 151.03957 N-methylcytisine
2 246.17360 2.94 2.135 163.07516, 134.09622, 59.04988 Sophocarpine
3 248.18896 − 3.67 2.351 179.05530,161.04527,89.02322 Sophoridine
4 248.18910 − 3.17 1.834 176.3145, 148.2457, 112.2569 Matrine
5 262.16841 − 3.65 2.592 181.05049,119.03400,89.02325 Oxysophocarpine
6 264.18394 − 0.52 24.975 247.2548, 205.7581, 148.2567 Oxymatrine
7 264.18395 − 3.19 50.755 211.06097, 167.07062, 149.05995, 123.04412, 71.01385 Sophoranol
8 384.22630 4.13 3.381 110.0603, 96.04457, 94.06555, 92.04989, 67.05498 Macrozamin
9 446.12215 − 2.50 2.976 263.07761,221.06653,179.05548,161.04482 Trifolirhizin
10 764.25163 0.84 17.229 152.01073, 123.04407, 108.0206, Liriodendrin